Log on / register
Feedback | Support | My details
Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus.
Lenert PS
Arthritis Res Ther 2006, 8:203
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
37%37%


 Editorial    
Inhibitory short synthetic oligodeoxynucleotides and lupus
Liu Z, Davidson A
Arthritis Research & Therapy 2009, 11:116 (26 June 2009)
 [Abstract] [Full text] [PDF]
2.
37%37%


 Research article    
DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Faslpr/lpr mice in vivo
Lenert P, Yasuda K, Busconi L, Nelson P, Fleenor C, Ratnabalasuriar RS, Nagy PL, Ashman RF, Rifkin IR, Marshak-Rothstein A
Arthritis Research & Therapy 2009, 11:R79 (28 May 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
3.
37%37%


 Review    
Toll-like receptors and innate immune responses in systemic lupus erythematosus
Lafyatis R, Marshak-Rothstein A
Arthritis Research & Therapy 2007, 9:222 (29 November 2007)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
4.
37%37%


 Review    
Developments in lupus 2006
Hansen A, Hiepe F, Dörner T
Arthritis Research & Therapy 2007, 9:215 (11 July 2007)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]

This article is also cited by a further 1 article in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.